Work

Abstract PD13-04: Rhenium (186Re) obisbemeda (rhenium nanoliposome,186RNL) for the treatment of leptomeningeal metastases (LM): Phase 1 dose escalation study results

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd13-04

Authors: A. Brenner, M. Youssef, P. Kumthekar, M. Schulder, J. Floyd, A. Bao, W. Phillips, P. Vroman, J. Michalek, M. Moore, M. Rosol, M. Hedrick

Institutions: The University of Texas at San Antonio Health Science Center, The University of Texas Southwestern Medical Center, Northwestern Medicine, Northwell Health, Case Western Reserve University

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130208770

Cites:

Cited by:

Related to: